Novel potential synthetic compounds from thiazolidin-4-one for infectious diseases

[1] Breidenstein EB, de la Fuente-Núñez C, Hancock RE. Pseudomonas aeruginosa all roads lead to resistance. Trends Microbiol. 2011; 19:419–26.BreidensteinEBdela Fuente-Núñez CHancockREPseudomonas aeruginosa all roads lead to resistanceTrends Microbiol201119419–2610.1016/j.tim.2011.04.00521664819Search in Google Scholar

[2] Abadi ATB. Helicobacter pylori emergence of a superbug. Front Med (Lausanne). 2014; 1:34. fmed.2014.00034AbadiATBHelicobacter pylori emergence of a superbugFront Med (Lausanne)2014134fmed.2014.00034Open DOISearch in Google Scholar

[3] Hawkes M, Barton M, Conly J, Nicolle L, Barry C, Ford-Jones EL. Community-associated MRSA: superbug at our doorstep. CMAJ. 2007; 176:54–6.HawkesMBartonMConlyJNicolleLBarryCFord-JonesElCommunity-associated MRSA: superbug at our doorstepCMAJ200717654–610.1503/cmaj.061370176459117200391Search in Google Scholar

[4] Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States, 2013. CDC. 2013; 15–7.Centers for Disease Control and Prevention Antibiotic resistance threats in the United States 2013CDC201315–7Search in Google Scholar

[5] Moellering RC Jr. The growing menace of community-acquired methicillin-resistant Staphylococcus aureus Ann Intern Med. 2006; 144:368–70.MoelleringRC JrThe growing menace of community-acquired methicillin-resistant Staphylococcus aureusAnn Intern Med2006144368–7010.7326/0003-4819-144-5-200603070-0001416520479Search in Google Scholar

[6] Nazir T, Abraham S, Islam A. Emergence of potential superbug Mycobacterium tuberculosis lessons from New Delhi mutant-1 bacterial strains. Int J Health Sci (Qassim). 2012; 6:87–94.NazirTAbrahamSIslamAEmergence of potential superbug Mycobacterium tuberculosis lessons from New Delhi mutant-1 bacterial strainsInt J Health Sci (Qassim)2012687–9410.12816/0005977352378923267308Search in Google Scholar

[7] Pham DT, Vo TMH, Truong P, Ho PT, Nguyen MQ. Antimicrobial activity of some novel 2-(2-iodophenylimino)-5-arylidenethiazolidin-4-one derivatives. Asian Biomed (Res, Rev, News). 2017; 11:405–12.PhamDTVoTMHTruongPHoPTNguyenMQAntimicrobial activity of some novel 2-(2-iodophenylimino)-5-arylidenethiazolidin-4-one derivativesAsian Biomed (Res, Rev, News)201711405–1210.1515/abm-2018-0015Search in Google Scholar